Bernd Hoppe
Director/Board Member at Oxalosis & Hyperoxaluria Foundation
Profile
Bernd Hoppe is currently the Director at Oxalosis & Hyperoxaluria Foundation.
Previously, he worked as the Vice President-Global Medical Affairs at Dicerna Pharmaceuticals, Inc.
Bernd Hoppe active positions
Companies | Position | Start |
---|---|---|
Oxalosis & Hyperoxaluria Foundation
Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Director/Board Member | - |
Former positions of Bernd Hoppe
Companies | Position | End |
---|---|---|
DICERNA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Oxalosis & Hyperoxaluria Foundation
Oxalosis & Hyperoxaluria Foundation Medical/Nursing ServicesHealth Services The Oxalosis & Hyperoxaluria Foundation is dedicated to eradicating all forms of hyperoxaluria disease forever. The non-profit company is based in New York, NY. The company's vision is a world without hyperoxaluria, and they are committed to improving the daily lives of people with this condition. | Health Services |
- Stock Market
- Insiders
- Bernd Hoppe